🔬Deep Research
ADMA · catalysts, narrative & risks
ADMA Biologics (ADMA) — Research Report as of August 27, 2026
Company Overview
ADMA Biologics is a commercial biopharmaceutical company focused on manufacturing, marketing, and developing specialty plasma-derived biologics. Its two key commercial products are ASCENIV (the flagship growth driver) and BIVIGAM (a standard intravenous immunoglobulin product facing competitive headwinds) [6][17].
Recent Catalysts (Last ~1–3 Months)
AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →